Company / Operating Income per Share
Bio-Techne Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.65
FY2025
5-year range
$0.65 / $4.04
FY2021-FY2025
Trend
-50.7%
vs FY2024
Sector context
#90 of 154
Health Care
What the data says
At $0.65, Bio-Techne's operating income per share ranks #90 of 154 in the Health Care sector. Operating Income per Share has declined for 3 consecutive years, from $4.04 in FY2022 to $0.65 in FY2025.
Based on SEC 10-K filings.
0.65 in FY2025 with a 5-year CAGR of -31.1%.
Declined from $1.51 to $0.65 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -45.7%
- 5-Year CAGR
- -31.1%
- 10-Year CAGR
- -
Sector benchmark
#90 of 154 in Health CareTop 58% of 154This company $0.65 Sector average $4.29
▼
-84.9% below sector average
Key checks
Key Insights
- Bio-Techne's operating income per share has declined for 3 consecutive years.
- In FY2025, operating income per share decreased 50.7% year-over-year.
- Ranks #90 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.65 | -50.7% |
| FY2024 | $1.31 | -13.5% |
| FY2023 | $1.51 | -62.5% |
| FY2022 | $4.04 | +5.9% |
| FY2021 | $3.82 | -8.1% |
| FY2020 | $4.15 | +6.4% |
| FY2019 | $3.90 | +9.0% |
| FY2018 | $3.58 | +10.6% |
| FY2017 | $3.24 | -20.1% |
| FY2016 | $4.05 | +2.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026